FARLONG HOLDING Corp

S-1/A amended

Farlong Holding Corporation's S-1/A filing details a firm commitment IPO of 4,000,000 common shares at $4.00 per share, totaling $16 million before underwriting discounts. The company remains a 'controlled company' post-offering, with existing shareholders retaining 90.9% voting power. Nasdaq listing approval is conditional, and the offering includes an over-allotment option. The company is an emerging growth entity under the JOBS Act, with reduced reporting requirements. Financials show a net tangible book value deficit of $3.5 million as of December 2025, with dilution risks for new investors.

S-1/A amended

Farlong Holding Corporation is conducting a firm commitment initial public offering (IPO) of 4,000,000 shares of common stock at an estimated price of $4.00 per share. The offering is conditioned on Nasdaq's approval for listing, and the company will remain a 'controlled company' under Nasdaq rules post-IPO, with significant voting control concentrated in Karin Mei Huang. The filing highlights risks related to Nasdaq listing approval, shareholder control, dilution of existing equity, and the company's status as an emerging growth company with reduced reporting requirements.

S-1/A amended

Farlong Holding Corp's S-1/A filing outlines a firm commitment initial public offering of 4,000,000 common shares at $4.00 per share, with an underwriter discount of 6.5%. The company anticipates listing on Nasdaq under the symbol 'AFA' but notes Nasdaq's final approval is pending. The offering highlights the company's status as a 'controlled company' under Nasdaq rules, with existing shareholders retaining 90.9% voting power post-offering. Risk factors include dependency on Nasdaq approval, significant dilution for new investors, and governance risks from concentrated ownership. The filing also details financials, including a net tangible book value of $(0.07) per share as of September 30, 2025, and updated dilution calculations.

S-1/A amended

Farlong Holding Corporation's S-1/A filing details a firm commitment initial public offering of 4,000,000 shares of common stock at $4.00 per share. The offering is conditional on Nasdaq's approval for listing, with the company currently classified as a 'controlled company' due to significant voting power concentration by existing shareholders. The filing highlights potential dilution for new investors and emphasizes risks related to market conditions, regulatory approvals, and corporate governance structures.

S-1/A amended

Farlong Holding Corporation's S-1/A filing details its initial public offering (IPO) of 4,000,000 shares of common stock at $4.00 per share, totaling $16 million before underwriting discounts. The offering includes an over-allotment option for 15% additional shares. The company, an emerging growth company, faces risks related to Nasdaq listing approval, controlled company governance, and significant share dilution. Proceeds will fund operations, with underwriters receiving 6.5% in discounts. The filing emphasizes the concentration of voting power among existing shareholders and uncertainties around regulatory approvals.

S-1/A amended

Farlong Holding Corporation's S-1/A filing details a firm commitment initial public offering (IPO) of common stock with an estimated price range of $[    ] to $[    ] per share. The offering is conditioned on Nasdaq's approval for listing, and the company remains a 'controlled company' under Nasdaq rules, with significant voting control concentrated in Karin Mei Huang. The filing highlights dilution risks for new investors, updates on capitalization, and compliance with reduced reporting requirements as an emerging growth company under the JOBS Act.

S-1 filed

Farlong Holding Corporation is conducting a firm commitment initial public offering (IPO) of its common stock, with an estimated price range between $[ ] and $[ ] per share. The company plans to list on Nasdaq under the symbol 'AFA,' though approval is pending. The offering includes underwriting discounts of 6.5% per share, with proceeds intended to fund operations. The company is classified as an emerging growth company under the JOBS Act and a 'controlled company' under Nasdaq rules, with significant voting control retained by KML Family Trust and KMA Trust. Dilution risks for new investors are highlighted, with net tangible book value per share expected to increase post-offering.

DRS/A amended

Farlong Holding Corporation's DRS/A filing outlines its initial public offering (IPO) of common stock, with an estimated price range of $[    ] to $[    ] per share. The company plans to list on Nasdaq, pending approval, and highlights its strategic shift toward proprietary BioPrecision formulations, reducing product SKUs from 260 to 80. The DirecTCM platform, launched in May 2025, now includes 75 active healthcare providers. The filing emphasizes risks related to U.S.-China trade tensions, supplier concentration, and its status as a 'controlled company' under Nasdaq rules.

DRS filed

Farlong Holding Corporation is preparing for its initial public offering (IPO) with a draft registration statement (DRS) filed confidentially with the SEC. The company, an emerging growth company, plans to list on Nasdaq but faces uncertainties, including Nasdaq's approval of its listing application. The offering aims to raise capital through a firm commitment IPO, with shares priced between $[    ] and $[    ]. The company has shifted its product focus to proprietary BioPrecision formulations, reducing SKUs from 260 to 80 in 2024, while facing risks related to U.S.-China trade tensions, supplier concentration, and significant operating losses.